CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY – Get Free Report) saw a large drop in short interest in November. As of November 15th, there was short interest totalling 4,900 shares, a drop of 98.9% from the October 31st total of 429,500 shares. Based on an average daily volume of 40,600 shares, the short-interest ratio is presently 0.1 days.
CSPC Pharmaceutical Group Price Performance
CSPCY stock traded up C$0.08 during mid-day trading on Wednesday, reaching C$2.64. The company had a trading volume of 5,526 shares, compared to its average volume of 40,428. The firm has a fifty day simple moving average of C$2.93 and a 200 day simple moving average of C$2.97. CSPC Pharmaceutical Group has a fifty-two week low of C$2.25 and a fifty-two week high of C$3.82.
CSPC Pharmaceutical Group Increases Dividend
The business also recently announced a dividend, which will be paid on Thursday, December 5th. Shareholders of record on Friday, November 1st will be paid a $0.0575 dividend. This is an increase from CSPC Pharmaceutical Group’s previous dividend of $0.06. The ex-dividend date is Friday, November 1st.
About CSPC Pharmaceutical Group
CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People's Republic of China, other Asian regions, North America, Europe, and internationally. The company operates through Finished Drugs, Bulk Products, and Functional Food and Others segments.
Further Reading
- Five stocks we like better than CSPC Pharmaceutical Group
- The Risks of Owning Bonds
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- NYSE Stocks Give Investors a Variety of Quality Options
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- What is a Dividend King?
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for CSPC Pharmaceutical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSPC Pharmaceutical Group and related companies with MarketBeat.com's FREE daily email newsletter.